GAB2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-55547
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to the following amino acid sequence: LSSSSQHLLRERKSSAPSHSSQPTLFTFEPPVSNHMQPTLSTSAPQEYLYLHQCISRRAENARSASFSQGTRASFLMRSDTAVQKLAQGNGHCVNGISGQVHGFYSLPKPSRHNTEFRDST
Reactivity Notes
Mouse 88%, Rat 85%
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for GAB2 Antibody
Immunocytochemistry/ Immunofluorescence: GAB2 Antibody [NBP2-55547]
Immunocytochemistry/Immunofluorescence: GAB2 Antibody [NBP2-55547] - Staining of human cell line SH-SY5Y shows localization to plasma membrane.Applications for GAB2 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Immunocytochemistry/Immunofluorescence Fixation Permeabilization: Use PFA/Triton X-100.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: GAB2
Long Name
GRB2-associated Binding Protein 2
Alternate Names
p100
Gene Symbol
GAB2
Additional GAB2 Products
Product Documents for GAB2 Antibody
Product Specific Notices for GAB2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...